Richard, Stéphane <br/><br/>
Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti-vascular endothelial growth factor receptor therapy.  [electronic resource] 

 -  Blood  May 2002 
 - 3851-3 p.  digital 
<br/><br/> Publication Type: Case Reports; Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood.v99.10.3851  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angiogenesis Inhibitors--adverse effects<br/>Enzyme Inhibitors--adverse effects<br/>Female<br/>Hematocrit<br/>Humans<br/>Indoles--adverse effects<br/>Kinetics<br/>Male<br/>Middle Aged<br/>Polycythemia--diagnosis<br/>Pyrroles--adverse effects<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Receptors, Growth Factor--antagonists & inhibitors<br/>Receptors, Vascular Endothelial Growth Factor<br/>von Hippel-Lindau Disease--therapy